Moreover, the current ATP-competitive inhibitors are not limited to the treatment of tumors and cancers, but also have applications in central nervous system diseases, viral infections, inflammation, and other disorders, which lay the foundation for expanding the indications of mTOR inhibitors. The gene discussed is MTOR; the disease is central nervous system disorder.